2019
DOI: 10.1007/978-3-030-00054-7_1
|View full text |Cite
|
Sign up to set email alerts
|

Chagas Disease: Past, Present, and Future

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 74 publications
0
1
0
Order By: Relevance
“…Much effort has been devoted to designing [14][15][16][17][18] or repurposing [19,20] drugs for SARS-CoV-2 targets, but such pursuits have not yet produced breakthrough success. Such disappointment is not surprising, given the historical challenges of developing antiviral therapeutics [21], but it is imperative to persevere and to innovate. The terrible global toll through a few short years of pandemic, the continuing threat of new coronavirus variants and hitherto undiscovered viral pathogens, and the rhetorical value of devising efficacious antiviral strategies all provide powerful incentives.…”
Section: Introductionmentioning
confidence: 99%
“…Much effort has been devoted to designing [14][15][16][17][18] or repurposing [19,20] drugs for SARS-CoV-2 targets, but such pursuits have not yet produced breakthrough success. Such disappointment is not surprising, given the historical challenges of developing antiviral therapeutics [21], but it is imperative to persevere and to innovate. The terrible global toll through a few short years of pandemic, the continuing threat of new coronavirus variants and hitherto undiscovered viral pathogens, and the rhetorical value of devising efficacious antiviral strategies all provide powerful incentives.…”
Section: Introductionmentioning
confidence: 99%